Lung Cancer Case Registry and Tissue Resource

This study is currently recruiting participants. (see Contacts and Locations)
Verified May 2014 by University of New Mexico
Sponsor:
Information provided by (Responsible Party):
University of New Mexico
ClinicalTrials.gov Identifier:
NCT00250848
First received: November 4, 2005
Last updated: May 19, 2014
Last verified: May 2014
  Purpose

Potential participants in the Lung Cancer Case Registry will be all patients diagnosed or evaluated for possible treatment of lung cancer at the Cancer Research and Treatment Center (CRTC) and New Mexico Veterans Health Care System (NMVHCS).


Condition
Lung Cancer

Study Type: Observational
Study Design: Observational Model: Cohort
Official Title: Lung Cancer Case Registry and Tissue Resource

Resource links provided by NLM:


Further study details as provided by University of New Mexico:

Primary Outcome Measures:
  • DNA Change [ Time Frame: one year ] [ Designated as safety issue: No ]

Biospecimen Retention:   Samples With DNA

Blood samples, and sputum (phlegm) samples.


Estimated Enrollment: 750
Study Start Date: March 2004
Estimated Study Completion Date: June 2016
Estimated Primary Completion Date: June 2015 (Final data collection date for primary outcome measure)
Detailed Description:

Lung cancer is the most common cause of cancer death in the US in both men and women. This research study will enroll lung cancer patients into a registry to study changes in DNA (or genetic material) that may be associated with development of lung cancer or other lung diseases such as chronic obstructive pulmonary disease (COPD). We will also study the role of eating habits on lung cancer diagnosis and treatment, as well as the effects of the disease and treatment on quality of patient's lives.

  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

All patients (male or female) with Lung cancer.

Criteria

Inclusion Criteria:

  • Potential participants in the Lung Cancer Case Registry will be all patients diagnosed or evaluated for possible treatment of lung cancer at the CRTC and NMVHCS. Recruiting will primarily be performed through the Multidisciplinary Chest Clinics held weekly at each hospital. These clinics are staffed by the Principal Investigator (PI) and Reza Mehran, MD, a thoracic surgeon at both hospitals and a co-investigator on this submission. Approximately 90% of all lung cancer cases diagnosed at the NMVHCS, and a somewhat smaller proportion of cases treated in the Cancer Center, are seen in these clinics. Additional cases will be identified through review of new patient visits to each hospital with a diagnosis of lung cancer; Drs. Crowell and Mehran also maintain weekly contact with pathology and oncology services at both facilities, which will facilitate case identification at NMVHCS and University Hospital. Finally, patient contact records will be correlated with tumor registry records at both hospitals, which will identify any cases not captured through the above mechanisms. Although these cases may be identified several weeks after initial diagnosis, all attempts will still be made to contact the patient and family for enrollment into the registry. Most Spanish-speaking patients served by the CRTC and the NMVHCS are bilingual, and a language barrier has not been a problem in other similar studies conducted by the PI. However, Spanish-speaking personnel are available to obtain consent and answer any questions if necessary.

Exclusion Criteria:

  • Patients will be excluded if they cannot provide written informed consent.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00250848

Contacts
Contact: Valerie Parks 505-925-0390 vparks@salud.unm.edu
Contact: Elizabeth Burki, PhD eburki@lrri.org

Locations
United States, New Mexico
University of New Mexico Cancer Center Recruiting
Albuquerque, New Mexico, United States, 87106
Contact: Valerie Parks    505-925-0390    vparks@salud.unm.edu   
Principal Investigator: Richard Crowell, MD         
Sub-Investigator: Elizabeth Burki, PhD         
New Mexico Veterans Administration Health Care System Active, not recruiting
Albuquerque, New Mexico, United States, 87108
Sponsors and Collaborators
University of New Mexico
Investigators
Principal Investigator: Richard Crowell, MD University of New Mexico
  More Information

No publications provided

Responsible Party: University of New Mexico
ClinicalTrials.gov Identifier: NCT00250848     History of Changes
Other Study ID Numbers: 2903C
Study First Received: November 4, 2005
Last Updated: May 19, 2014
Health Authority: United States: Institutional Review Board

Keywords provided by University of New Mexico:
Lung Diseases
Cancer

Additional relevant MeSH terms:
Lung Neoplasms
Respiratory Tract Neoplasms
Thoracic Neoplasms
Neoplasms by Site
Neoplasms
Lung Diseases
Respiratory Tract Diseases

ClinicalTrials.gov processed this record on August 28, 2014